BR9510520A - Proteína de capsídeo de vírus papiloma isolada e purificada capsídeos partículas semelhantes a vírus processo de produzir a proteína purificada proteína do vírus papilona recombinante vacina composições farmacêuticas processo de tratamento ou de prevenção contra a infecção por vírus papilona kit para a detecção de vírus papiloma ou de anticorpos a vírus papiloma processos para a produção de uma proteína de capsídeo de vírus papilona recombinante para induzir uma resposta imunológica em um animalvertebrado sistema sintetico processos de obtenção de partículas semelhantes a vírus de obtenção da capsideos prificados capsideos de virus papilona - Google Patents
Proteína de capsídeo de vírus papiloma isolada e purificada capsídeos partículas semelhantes a vírus processo de produzir a proteína purificada proteína do vírus papilona recombinante vacina composições farmacêuticas processo de tratamento ou de prevenção contra a infecção por vírus papilona kit para a detecção de vírus papiloma ou de anticorpos a vírus papiloma processos para a produção de uma proteína de capsídeo de vírus papilona recombinante para induzir uma resposta imunológica em um animalvertebrado sistema sintetico processos de obtenção de partículas semelhantes a vírus de obtenção da capsideos prificados capsideos de virus papilonaInfo
- Publication number
- BR9510520A BR9510520A BR9510520A BR9510520A BR9510520A BR 9510520 A BR9510520 A BR 9510520A BR 9510520 A BR9510520 A BR 9510520A BR 9510520 A BR9510520 A BR 9510520A BR 9510520 A BR9510520 A BR 9510520A
- Authority
- BR
- Brazil
- Prior art keywords
- virus
- papillone
- recombinant
- capsid protein
- purified
- Prior art date
Links
- 241001631646 Papillomaviridae Species 0.000 title 3
- 238000000034 method Methods 0.000 title 3
- 108090000565 Capsid Proteins Proteins 0.000 title 2
- 102100023321 Ceruloplasmin Human genes 0.000 title 2
- 241000700605 Viruses Species 0.000 title 2
- 210000000234 capsid Anatomy 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 230000028993 immune response Effects 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33936894A | 1994-11-14 | 1994-11-14 | |
| PCT/US1995/015027 WO1996015247A1 (en) | 1994-11-14 | 1995-11-13 | Purified papillomavirus proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9510520A true BR9510520A (pt) | 1998-07-14 |
Family
ID=23328696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9510520A BR9510520A (pt) | 1994-11-14 | 1995-11-13 | Proteína de capsídeo de vírus papiloma isolada e purificada capsídeos partículas semelhantes a vírus processo de produzir a proteína purificada proteína do vírus papilona recombinante vacina composições farmacêuticas processo de tratamento ou de prevenção contra a infecção por vírus papilona kit para a detecção de vírus papiloma ou de anticorpos a vírus papiloma processos para a produção de uma proteína de capsídeo de vírus papilona recombinante para induzir uma resposta imunológica em um animalvertebrado sistema sintetico processos de obtenção de partículas semelhantes a vírus de obtenção da capsideos prificados capsideos de virus papilona |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0789767B1 (pt) |
| JP (1) | JPH11500002A (pt) |
| KR (1) | KR987000420A (pt) |
| CN (1) | CN1173203A (pt) |
| AR (1) | AR004464A1 (pt) |
| AT (1) | ATE245192T1 (pt) |
| AU (1) | AU708737B2 (pt) |
| BR (1) | BR9510520A (pt) |
| CZ (1) | CZ145297A3 (pt) |
| DE (1) | DE69531308T2 (pt) |
| DK (1) | DK0789767T3 (pt) |
| ES (1) | ES2201129T3 (pt) |
| FI (1) | FI972030A (pt) |
| HR (1) | HRP950557A2 (pt) |
| HU (1) | HUT77559A (pt) |
| MX (1) | MX9703570A (pt) |
| NZ (1) | NZ298224A (pt) |
| PT (1) | PT789767E (pt) |
| RU (1) | RU2161651C2 (pt) |
| SK (1) | SK281878B6 (pt) |
| UA (1) | UA35639C2 (pt) |
| WO (1) | WO1996015247A1 (pt) |
| YU (1) | YU71195A (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6153201A (en) * | 1993-03-09 | 2000-11-28 | University Of Rochester | Oral immunization with papillomavirus virus-like particles |
| WO1996009375A1 (en) * | 1994-09-22 | 1996-03-28 | Merck & Co., Inc. | Dna encoding human papillomavirus type 6a |
| GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
| EP0973546B1 (en) * | 1997-04-08 | 2004-03-17 | Merck & Co., Inc. | Stabilized human papillomavirus formulations |
| IL141130A0 (en) * | 1998-08-14 | 2002-02-10 | Merck & Co Inc | Process for purifying human papilloma virus-like particles |
| AUPP765398A0 (en) | 1998-12-11 | 1999-01-14 | University Of Queensland, The | Treatment of papillomavirus infections |
| AU764138B2 (en) | 1999-02-05 | 2003-08-14 | Merck Sharp & Dohme Corp. | Human papilloma virus vaccine formulations |
| GB0206360D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
| EP1501921B2 (en) | 2002-04-30 | 2012-07-25 | Oncolytics Biotech Inc. | Improved viral purification methods |
| MY140664A (en) | 2003-09-29 | 2010-01-15 | Merck Sharp & Dohme | Optimized expression of hpv 45 l1 in yeast |
| US7901921B2 (en) | 2004-10-22 | 2011-03-08 | Oncolytics Biotech Inc. | Viral purification methods |
| ES2559421T3 (es) * | 2007-03-14 | 2016-02-12 | Takeda Vaccines, Inc. | Purificación de partículas similares a virus |
| EP2444103B1 (en) * | 2009-06-19 | 2017-12-20 | Eyegene Inc. | Vaccine for cervical cancer |
| JOP20130186B1 (ar) | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
| CN103936840B (zh) * | 2013-01-18 | 2019-04-09 | 北京康乐卫士生物技术股份有限公司 | 重组的人乳头瘤病毒33型l1蛋白及其用途 |
| CN113278064B (zh) * | 2021-07-20 | 2021-11-02 | 山东信得科技股份有限公司 | 一种用于胚毒类抗原净化处理的方法及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0595935T3 (da) * | 1991-07-19 | 2003-07-21 | Csl Ltd | Papillomavirusvaccine |
| US5437951A (en) * | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
| ATE492289T1 (de) * | 1993-03-09 | 2011-01-15 | Univ Rochester | Herstellung von menschlichen papillomavirus hbv- 11 kapsidprotein l1 und virus-ähnliche partikeln |
| HUT76354A (en) * | 1994-05-16 | 1997-08-28 | Merck & Co Inc | Papillomavirus vaccines |
-
1995
- 1995-11-10 AR ARP950100143A patent/AR004464A1/es active IP Right Grant
- 1995-11-13 KR KR1019970703497A patent/KR987000420A/ko not_active Application Discontinuation
- 1995-11-13 CN CN95197322A patent/CN1173203A/zh active Pending
- 1995-11-13 UA UA97062806A patent/UA35639C2/uk unknown
- 1995-11-13 ES ES95942431T patent/ES2201129T3/es not_active Expired - Lifetime
- 1995-11-13 RU RU97110164/13A patent/RU2161651C2/ru active
- 1995-11-13 SK SK594-97A patent/SK281878B6/sk unknown
- 1995-11-13 CZ CZ971452A patent/CZ145297A3/cs unknown
- 1995-11-13 MX MX9703570A patent/MX9703570A/es unknown
- 1995-11-13 DE DE69531308T patent/DE69531308T2/de not_active Expired - Lifetime
- 1995-11-13 BR BR9510520A patent/BR9510520A/pt not_active Application Discontinuation
- 1995-11-13 WO PCT/US1995/015027 patent/WO1996015247A1/en not_active Application Discontinuation
- 1995-11-13 JP JP8516355A patent/JPH11500002A/ja active Pending
- 1995-11-13 DK DK95942431T patent/DK0789767T3/da active
- 1995-11-13 PT PT95942431T patent/PT789767E/pt unknown
- 1995-11-13 HU HU9800514A patent/HUT77559A/hu unknown
- 1995-11-13 EP EP95942431A patent/EP0789767B1/en not_active Expired - Lifetime
- 1995-11-13 AT AT95942431T patent/ATE245192T1/de active
- 1995-11-13 AU AU43658/96A patent/AU708737B2/en not_active Expired
- 1995-11-13 HR HR08/339,368A patent/HRP950557A2/hr not_active Application Discontinuation
- 1995-11-13 NZ NZ298224A patent/NZ298224A/xx unknown
- 1995-11-14 YU YU71195A patent/YU71195A/sh unknown
-
1997
- 1997-05-13 FI FI972030A patent/FI972030A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR987000420A (ko) | 1998-03-30 |
| NZ298224A (en) | 1999-05-28 |
| CN1173203A (zh) | 1998-02-11 |
| HRP950557A2 (en) | 1997-08-31 |
| EP0789767B1 (en) | 2003-07-16 |
| JPH11500002A (ja) | 1999-01-06 |
| WO1996015247A1 (en) | 1996-05-23 |
| UA35639C2 (uk) | 2001-04-16 |
| SK281878B6 (sk) | 2001-08-06 |
| DE69531308D1 (de) | 2003-08-21 |
| AR004464A1 (es) | 1998-12-16 |
| CZ145297A3 (en) | 1997-10-15 |
| ES2201129T3 (es) | 2004-03-16 |
| PT789767E (pt) | 2003-11-28 |
| RU2161651C2 (ru) | 2001-01-10 |
| MX9703570A (es) | 1997-08-30 |
| AU4365896A (en) | 1996-06-06 |
| HUT77559A (hu) | 1998-06-29 |
| DE69531308T2 (de) | 2004-04-15 |
| FI972030A0 (fi) | 1997-05-13 |
| SK59497A3 (en) | 1998-03-04 |
| EP0789767A1 (en) | 1997-08-20 |
| YU71195A (sh) | 1999-06-15 |
| DK0789767T3 (da) | 2003-10-20 |
| AU708737B2 (en) | 1999-08-12 |
| FI972030A (fi) | 1997-05-13 |
| ATE245192T1 (de) | 2003-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9510520A (pt) | Proteína de capsídeo de vírus papiloma isolada e purificada capsídeos partículas semelhantes a vírus processo de produzir a proteína purificada proteína do vírus papilona recombinante vacina composições farmacêuticas processo de tratamento ou de prevenção contra a infecção por vírus papilona kit para a detecção de vírus papiloma ou de anticorpos a vírus papiloma processos para a produção de uma proteína de capsídeo de vírus papilona recombinante para induzir uma resposta imunológica em um animalvertebrado sistema sintetico processos de obtenção de partículas semelhantes a vírus de obtenção da capsideos prificados capsideos de virus papilona | |
| Wiktor et al. | Antigenic properties of rabies virus components | |
| US6267967B1 (en) | Virus preparations and methods | |
| JP2004536785A5 (pt) | ||
| JP2009102327A (ja) | パピローマウイルス様粒子、融合タンパク質並びにそれらの製造方法 | |
| IL173071A0 (en) | Functional influenza virus-like particles (vlps) | |
| BR0111830A (pt) | Método de produção de partìculas semelhantes ao vìrus da influenza (vlps), vlps da influenza, vlps quiméricas, proteìnas da influenza, composições imunogênica e farmacêutica, métodos de imunizar contra a infecção causada pelo vìrus da influenza ou por um microorganismo patogênico outro que não o vìrus da influenza, método de tratamento, e, célula hospedeira transfectada, infectada ou transformada com uma molécula de dna recombinante | |
| DE69434383D1 (de) | Herstellung von menschlichem papillomavirus hüllprotein und virus-ähnlichen teilchen | |
| HUP9801334A2 (hu) | A 18-as típusú humán papillomavírust kódoló DNS | |
| JP2009297036A (ja) | 高張塩溶液を用いた培養細胞からのウイルス回収法 | |
| KR950700756A (ko) | 바이러스성 질병 및 악성종양의 치료를 위한, 생바이러스(live virus)를 함유하는 백신(VACCINE CONTAINING LIVE VIRUSES FOR THERAPY OF VIRAL DISEASES AND MALIGNANCIES) | |
| CA2115927A1 (en) | Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus | |
| Clerx et al. | Qalyub virus, a member of the newly proposed Nairovirus genus (Bunyavividae) | |
| Roos et al. | Characterization of a cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus | |
| SE9202968D0 (sv) | New peptides, diagnostic antigens, use thereof, vaccines and medicaments | |
| US6991929B1 (en) | Hepatitis A vaccines | |
| JPS59101426A (ja) | Ｂ型肝炎感染予防用ワクチンの製造方法 | |
| AU6383296A (en) | Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection | |
| EP1453535A2 (en) | Enveloped virus vaccine and method for production | |
| WO1997004099A3 (de) | Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen | |
| JP3109886B2 (ja) | 経鼻接種用ワクチン | |
| HUP0204446A2 (en) | Gm-negative ehv-mutants | |
| JP2008525023A (ja) | ウイルス製剤及びその製造方法 | |
| DK257887D0 (da) | Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden | |
| RS55404A (en) | An avian embryo particulate biomass for the production of virus antigens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| FC | Decision: refusal |